The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study

Abstract Background The gonadotropin-releasing hormone agonist (GnRH-a) has been used in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles for a long time. This paper evaluates the efficacy and safety of two commonly used protocols (follicular-phase depot GnRH-a protocol and...

Full description

Bibliographic Details
Main Authors: Ying Zhang, Wenxian Zhao, Yifan Han, Xin Chen, Shaoyuan Xu, Yueyue Hu, Honglu Diao, Changjun Zhang
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Reproductive Biology and Endocrinology
Subjects:
Online Access:https://doi.org/10.1186/s12958-022-01014-0
_version_ 1798001642293952512
author Ying Zhang
Wenxian Zhao
Yifan Han
Xin Chen
Shaoyuan Xu
Yueyue Hu
Honglu Diao
Changjun Zhang
author_facet Ying Zhang
Wenxian Zhao
Yifan Han
Xin Chen
Shaoyuan Xu
Yueyue Hu
Honglu Diao
Changjun Zhang
author_sort Ying Zhang
collection DOAJ
description Abstract Background The gonadotropin-releasing hormone agonist (GnRH-a) has been used in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles for a long time. This paper evaluates the efficacy and safety of two commonly used protocols (follicular-phase depot GnRH-a protocol and daily mid-luteal long GnRH-a protocol) in normal responders undergoing IVF/ICSI using propensity score matching (PSM) analysis. Methods A total of 6,816 infertile women treated within the period from January 2016 to September 2020 were stratified into cohorts. A total of 2,851 patients received the long-acting group (depot GnRH-a protocol), and 1,193 used the short-acting group (long GnRH-a protocol) after the data-selection process. PSM was utilized for sampling by up to 1:1 nearest neighbour matching to adjust the numerical difference and balance the confounders between groups. The primary outcome was the live birth rate (LBR). Multivariable logistic analysis was used to evaluate the difference between these two protocols in relation to the LBR. Result(s) In this study, 1:1 propensity score matching was performed to create a perfect match of 964 patients in each group. After matching, the blastocyst formation rates, oestradiol (E2) value on Day hCG + 9, progesterone (P) value on Day hCG + 9, implantation rates, clinical pregnancy rates, and LBR were more favourable in the depot GnRH-a protocol than in the long GnRH-a protocol (P < 0.05). However, the moderate or severe OHSS rates were higher in the depot group than in the long group (P < 0.001). There were no significant differences in endometrial thickness, luteal support medication, early pregnancy loss rates, mid- and late-term pregnancy loss rates, or foetal malformation rates between the two protocols. Conclusion(s) Compared with the daily short-acting GnRH agonist protocol, the follicular-phase depot GnRH-a protocol might improve LBRs in normogonadotropic women without discernible differences in luteal function and child health.
first_indexed 2024-04-11T11:39:32Z
format Article
id doaj.art-dbd4ae53f6764dd48bc1ce01e3fc387b
institution Directory Open Access Journal
issn 1477-7827
language English
last_indexed 2024-04-11T11:39:32Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Reproductive Biology and Endocrinology
spelling doaj.art-dbd4ae53f6764dd48bc1ce01e3fc387b2022-12-22T04:25:52ZengBMCReproductive Biology and Endocrinology1477-78272022-09-0120111110.1186/s12958-022-01014-0The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort studyYing Zhang0Wenxian Zhao1Yifan Han2Xin Chen3Shaoyuan Xu4Yueyue Hu5Honglu Diao6Changjun Zhang7Reproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineReproductive Medicine Center, Renmin Hospital, Hubei University of MedicineAbstract Background The gonadotropin-releasing hormone agonist (GnRH-a) has been used in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles for a long time. This paper evaluates the efficacy and safety of two commonly used protocols (follicular-phase depot GnRH-a protocol and daily mid-luteal long GnRH-a protocol) in normal responders undergoing IVF/ICSI using propensity score matching (PSM) analysis. Methods A total of 6,816 infertile women treated within the period from January 2016 to September 2020 were stratified into cohorts. A total of 2,851 patients received the long-acting group (depot GnRH-a protocol), and 1,193 used the short-acting group (long GnRH-a protocol) after the data-selection process. PSM was utilized for sampling by up to 1:1 nearest neighbour matching to adjust the numerical difference and balance the confounders between groups. The primary outcome was the live birth rate (LBR). Multivariable logistic analysis was used to evaluate the difference between these two protocols in relation to the LBR. Result(s) In this study, 1:1 propensity score matching was performed to create a perfect match of 964 patients in each group. After matching, the blastocyst formation rates, oestradiol (E2) value on Day hCG + 9, progesterone (P) value on Day hCG + 9, implantation rates, clinical pregnancy rates, and LBR were more favourable in the depot GnRH-a protocol than in the long GnRH-a protocol (P < 0.05). However, the moderate or severe OHSS rates were higher in the depot group than in the long group (P < 0.001). There were no significant differences in endometrial thickness, luteal support medication, early pregnancy loss rates, mid- and late-term pregnancy loss rates, or foetal malformation rates between the two protocols. Conclusion(s) Compared with the daily short-acting GnRH agonist protocol, the follicular-phase depot GnRH-a protocol might improve LBRs in normogonadotropic women without discernible differences in luteal function and child health.https://doi.org/10.1186/s12958-022-01014-0Live birth rateLuteal supportNeonatal outcomesDepot GnRH agonist protocolLong GnRH agonist protocol
spellingShingle Ying Zhang
Wenxian Zhao
Yifan Han
Xin Chen
Shaoyuan Xu
Yueyue Hu
Honglu Diao
Changjun Zhang
The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
Reproductive Biology and Endocrinology
Live birth rate
Luteal support
Neonatal outcomes
Depot GnRH agonist protocol
Long GnRH agonist protocol
title The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
title_full The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
title_fullStr The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
title_full_unstemmed The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
title_short The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study
title_sort follicular phase depot gnrh agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid luteal gnrh agonist protocol a single centre retrospective propensity score matched cohort study
topic Live birth rate
Luteal support
Neonatal outcomes
Depot GnRH agonist protocol
Long GnRH agonist protocol
url https://doi.org/10.1186/s12958-022-01014-0
work_keys_str_mv AT yingzhang thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT wenxianzhao thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT yifanhan thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT xinchen thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT shaoyuanxu thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT yueyuehu thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT hongludiao thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT changjunzhang thefollicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT yingzhang follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT wenxianzhao follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT yifanhan follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT xinchen follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT shaoyuanxu follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT yueyuehu follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT hongludiao follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy
AT changjunzhang follicularphasedepotgnrhagonistprotocolresultsinahigherlivebirthratewithoutdiscernibledifferencesinlutealfunctionandchildhealthversusthedailymidlutealgnrhagonistprotocolasinglecentreretrospectivepropensityscorematchedcohortstudy